STUDY SUMMARY
Lung Cancer Model: TM00212
NSG™ mice engrafted with passage 3 tumors for model TM00212
were randomly assigned to one of these treatment groups:
- 5% dextrose in water (vehicle control; 5 ml/kg; IV once per week for two times; N=9)
- Cisplatin (2 mg/kg; IV once per week for two times; N=10)
- Docetaxel (10 mg/kg; IV once per week for two times; N=9)
- Trametinib (3 mg/kg; PO five times a week for 4 times; N=10)
Mice were monitored for tumor volume at least twice per week throughout the study period.
• Treatment groups
• Individual subjects / spider plot
• RECIST scores
• Waterfall plot
• TGI plot
• Protocols
Hide/show treatment groups
Hide/show treatment groups
Hide/show treatment groups